A recent study showed that after UCB infusion in AML patients, immune functions were enhanced by promoting cell proliferation and cytokine secretion of CD8+T cells and natural killer cells and mitigating the immunosuppressive effects of CD14+ monocytes (29). Here, CD14 is linked to acute myeloid leukemia.